# Geneplus-Beijing

Source: https://onco.cc/companies/geneplus/  
OnCo record `geneplus` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A Beijing cancer genomics company whose researchers co-developed the INSPECTOR methylation blood test for eight cancers.

## Summary

Geneplus-Beijing, whose employees co-authored the INSPECTOR study with Sun Yat-sen University Cancer Center (Cancer Communications 2025), develops an enzyme-assisted methylation sequencing test for eight cancers through its early cancer screening research department.

## Fields

- Kind: Company
- Last checked: 2026-11-03
- Also known as: Geneplus; GenePlus-Beijing Institute
- HQ: Beijing
- Type: diagnostics

## Sources

- INSPECTOR, Cancer Communications 2025: https://doi.org/10.1002/cac2.70071

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Cell-free DNA methylation tests](https://onco.cc/technologies/cfdna-methylation-testing/), [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [INSPECTOR methylation test (Geneplus)](https://onco.cc/drugs/inspector-mced/)
- key papers: [The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA](https://onco.cc/key-papers/paper-inspector-geneplus-cancer-commun-2025/)

---
JSON: https://onco.cc/api/v1/entities/geneplus.json